Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperpigmentation disorders
ADR ID BADD_A02139
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.05      Pigmentation disorders
23.05.01      Hyperpigmentation disorders
Description Not Available
MedDRA Code 10020713
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00723Doxorubicin0.000302%
BADD_D00749Efavirenz--
BADD_D00765Empagliflozin0.000200%
BADD_D00766Emtricitabine--
BADD_D00784Epirubicin--
BADD_D00785Epirubicin hydrochloride--
BADD_D00793Equilin sulfate--
BADD_D00800Erlotinib--
BADD_D00820Esterified estrogens--
BADD_D00821Estradiol--
BADD_D00822Estradiol acetate--
BADD_D00823Estradiol cypionate--
BADD_D00824Estradiol hemihydrate--
BADD_D00825Estradiol valerate--
BADD_D00829Estriol--
BADD_D00830Estrofen--
BADD_D00831Estrogens--
BADD_D00832Estrogens conjugated synthetic a--
BADD_D00833Estrogens conjugated synthetic b--
BADD_D00834Estrone--
BADD_D00835Estrone sulfate--
BADD_D00836Estropipate--
BADD_D00844Ethinyl estradiol--
BADD_D00850Etodolac--
BADD_D00852Etonogestrel0.001152%
BADD_D00858Everolimus0.000336%
BADD_D00873Fenofibrate0.000039%
BADD_D00886Ferrosoferric oxide--
BADD_D00898Finasteride0.000211%
BADD_D00908Floxuridine--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 8 Pages
ADReCS-Target
ADR Term Drug Name Target